These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11979821)

  • 1. [Proton pump inhibitor-based quadruple therapy regimen for Helicobacter pylori infection].
    Ohkusa T; Sato N
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():431-4. PubMed ID: 11979821
    [No Abstract]   [Full Text] [Related]  

  • 2. [New triple therapy for Helicobacter pylori infection].
    Satoh K
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():414-9. PubMed ID: 11979817
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of PPI/AM re-treatment regimen for the patients with Helicobacter pylori infection after failure of first line eradication therapy by PPI/AC regimens].
    Nagahara A; Miyazaki A; Miwa H; Sato N
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():435-8. PubMed ID: 11979822
    [No Abstract]   [Full Text] [Related]  

  • 4. [Proton pump inhibitors: Efficacy of lansoprazole in eradicating Helicobacter pylori].
    Kawata H; Satoh K
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():640-4. PubMed ID: 11979862
    [No Abstract]   [Full Text] [Related]  

  • 5. [Proton pump inhibitors: Rabeprazole].
    Yoshino J
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():645-9. PubMed ID: 11979863
    [No Abstract]   [Full Text] [Related]  

  • 6. 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study.
    Paoluzi P; Iacopini F; Crispino P; Nardi F; Bella A; Rivera M; Rossi P; Gurnari M; Caracciolo F; Zippi M; Pica R
    Helicobacter; 2006 Dec; 11(6):562-8. PubMed ID: 17083378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [H. pylori eradication therapy and natural history of peptic ulcer].
    Haruma K; Kamada T; Kusunoki H
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():49-53. PubMed ID: 11979833
    [No Abstract]   [Full Text] [Related]  

  • 8. [Role of pantoprazole in the eradicating treatment of Helicobacter pylori].
    Gisbert JP; Boixeda D; Martín de Argila C; García Plaza A
    Rev Clin Esp; 1998 Oct; 198(10):678-83. PubMed ID: 9844458
    [No Abstract]   [Full Text] [Related]  

  • 9. [Proton pump inhibitors: Omeprazole].
    Iwasaki A
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():633-9. PubMed ID: 11979860
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative efficacy of proton pump inhibitors in children].
    Kornienko EA; Klochko OG
    Eksp Klin Gastroenterol; 2003; (6):72-5. PubMed ID: 15065532
    [No Abstract]   [Full Text] [Related]  

  • 11. Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
    Chey WD; Fisher L; Elta GH; Barnett JL; Nostrant T; DelValle J; Hasler WL; Scheiman JM
    Am J Gastroenterol; 1997 Sep; 92(9):1483-6. PubMed ID: 9317068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-line treatment for Helicobacter pylori infection in Japan: proton pump inhibitor-based amoxicillin and metronidazole regimen.
    Nagahara A; Miwa H; Kawabe M; Kurosawa A; Asaoka D; Hojo M; Iijima K; Terai T; Ohkusa T; Miyazaki A; Sato N
    J Gastroenterol; 2004 Nov; 39(11):1051-5. PubMed ID: 15580397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population.
    Shimoyama T; Fukuda S; Mikami T; Fukushi M; Munakata A
    J Gastroenterol; 2004 Oct; 39(10):927-30. PubMed ID: 15549444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Second line treatment regimen of PPI + AMPC + MNZ for patients with clarithromycin-resistant Helicobacter pylori infection].
    Tokunaga K; Takahashi S
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():445-8. PubMed ID: 11979824
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of Helicobacter pylori infection: summary of a meeting at the Fourth United European Gastroenterology Week, September 20, 1995.
    Mégraud F; Malfertheiner P
    Helicobacter; 1996 Jun; 1(2):118-21. PubMed ID: 9398889
    [No Abstract]   [Full Text] [Related]  

  • 16. [Eradication therapy for clarithromycin-resistant and metronidazole-resistant Helicobacter pylori infection].
    Inoue K; Sugano K
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():460-4. PubMed ID: 11979828
    [No Abstract]   [Full Text] [Related]  

  • 17. [Practice guidelines for diagnosis and treatment of Helicobacter pylori infections and their application in clinical practice].
    Sugano K
    Nihon Naika Gakkai Zasshi; 2002 Mar; 91 Suppl():32-7. PubMed ID: 11989260
    [No Abstract]   [Full Text] [Related]  

  • 18. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
    Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
    J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose rabeprazole, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese patients.
    Wong WM; Huang J; Xia HH; Fung FM; Tong TS; Cheung KL; Ho VY; Lai KC; Chan CK; Chan AO; Hui CK; Lam SK; Wong BC
    J Gastroenterol Hepatol; 2005 Jun; 20(6):935-40. PubMed ID: 15946144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
    Murakami K; Okimoto T; Kodama M; Sato R; Miyajima H; Ono M; Inoue K; Watanabe K; Otsu S; Fujioka T
    Helicobacter; 2006 Oct; 11(5):436-40. PubMed ID: 16961805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.